A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It Works
Clinical trial NCT05134987 · COMPLETED
Trial details
- NCT number
- NCT05134987
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2022-05-06
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.